SCHEMBL806516

SCHEMBL806516

Cc1cc(C)c2cc(O)ccc2c1

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.54
CYP2A6 P11509 1/20 0.54
PTGES O14684 1/20 0.50
ESR1 P03372 9/20 0.46
ESR2 Q92731 9/20 0.46
DYRK1A Q13627 1/20 0.41
RAPGEF4 Q8WZA2 2/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
MCL1 Q07820 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9623383 0.84 ESR2 (0.52) CYP1A2ESR1ESR2DYRK1AKDM4E
SCHEMBL13534212 0.83 ESR1 (0.43) CYP1A2CYP2A6PTGESESR1ESR2
SCHEMBL597701 0.79 CYP1A2 (0.60) CYP1A2CYP2A6RAPGEF4KDM4EALDH1A1
SCHEMBL15869807 0.76 CYP1A2 (0.52) CYP1A2CYP2A6ESR1ESR2KDM4E
SCHEMBL29276380 0.75 CYP1A2 (0.45) CYP1A2CYP2A6ESR2KDM4EALDH1A1
SCHEMBL12787309 0.75 PTGES (0.55) CYP1A2PTGESESR1ESR2RAPGEF4
SCHEMBL12962944 0.74 CYP1A2 (0.52) CYP1A2CYP2A6ESR1ESR2DYRK1A
SCHEMBL1402659 0.74 CYP1A2 (0.63) CYP1A2CYP2A6ESR1ESR2ALDH1A1
SCHEMBL21240955 0.74 CYP2A6 (0.54) CYP1A2CYP2A6RAPGEF4KDM4EALDH1A1
SCHEMBL806482 0.74 ESR1 (0.43) CYP1A2PTGESESR1ESR2DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012036253-A1 HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORDERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE. OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2012-03-22 WO disclosed